Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
PT Kalbe Farma Tbk (PTKFY)
OTHER OTC:PTKFY
Holding PTKFY?
Track your performance easily
PTKFY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$17.23 - $24.27
Previous Close$21.35
Volume41.00
Average Volume (3M)1.86K
Market Cap
$5.13B
Enterprise Value$5.05B
Total Cash (Recent Filing)Rp4.10T
Total Debt (Recent Filing)Rp1.17T
Price to Earnings (P/E)26.2
Beta0.15
Next Earnings
Oct 30, 2024EPS EstimateN/A
Last Dividend Ex-Date
May 31, 2024Dividend Yield1.21%
Share Statistics
EPS (TTM)0.84
Shares OutstandingN/A
10 Day Avg. Volume14
30 Day Avg. Volume1,857
Standard Deviation0.11
R-Squared0.17
Alpha-0.00341
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)3.48
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PT Kalbe Farma Tbk News
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00%
Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
PTKFY FAQ
What was PT Kalbe Farma Tbk’s price range in the past 12 months?
PT Kalbe Farma Tbk lowest stock price was $17.23 and its highest was $24.27 in the past 12 months.
What is PT Kalbe Farma Tbk’s market cap?
Currently, no data Available
When is PT Kalbe Farma Tbk’s upcoming earnings report date?
PT Kalbe Farma Tbk’s upcoming earnings report date is Oct 30, 2024 which is in 59 days.
How were PT Kalbe Farma Tbk’s earnings last quarter?
PT Kalbe Farma Tbk released its earnings results on Jul 31, 2024. The company reported $0.229 earnings per share for the quarter, beating the consensus estimate of N/A by $0.229.
Is PT Kalbe Farma Tbk overvalued?
According to Wall Street analysts PT Kalbe Farma Tbk’s price is currently Overvalued.
Does PT Kalbe Farma Tbk pay dividends?
PT Kalbe Farma Tbk pays a Annually dividend of $0.27 which represents an annual dividend yield of 1.21%. See more information on PT Kalbe Farma Tbk dividends here
What is PT Kalbe Farma Tbk’s EPS estimate?
PT Kalbe Farma Tbk’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PT Kalbe Farma Tbk have?
PT Kalbe Farma Tbk has 234,375,600 shares outstanding.
What happened to PT Kalbe Farma Tbk’s price movement after its last earnings report?
PT Kalbe Farma Tbk reported an EPS of $0.229 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.875%.
Which hedge fund is a major shareholder of PT Kalbe Farma Tbk?
Currently, no hedge funds are holding shares in PTKFY
---
PT Kalbe Farma Tbk Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-10.50%
12-Months-Change
Fundamentals
Return on Equity
14.57%
Trailing 12-Months
Asset Growth
-4.03%
Trailing 12-Months
Company Description
PT Kalbe Farma Tbk
PT Kalbe Farma Tbk engages in the development, production, distribution, and trade of pharmaceutical products. It operates through the following segments: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution & Logistic. The Prescription Pharmaceutical segment offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores throughout Indonesia. The Consumer Health segment provides over-the-counter drugs, consumer products, food supplements, preventive products, energy drinks, and healthy ready-to-drink products. The Nutritionals segment sells biscuits, cereals, and milk products for infants, toddlers, children, pre-teenagers, adults, expectant and lactating mothers, and elderly; as well as nutritional products for consumers with special medical needs. The Distribution & Logistic segment maintains distribution of the company's and third party principal's products across Indonesia, and focuses on the trading of raw material, medical devices, and retail health service. The company founded by Boenyamin Setiawan on September 10, 1966 and is headquartered in Jakarta, Indonesia.
---
Technical Analysis
---